Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.01M

combined est. value

Stock	Shares	Price	Value	Weight	As of
AAGILENT TECHNOLOGIES, INC.	5,548	$130.69	$725.1K	72%	2026-05-29
RCKTROCKET PHARMACEUTICALS, INC.	67,082	$4.19	$281.1K	28%	2026-06-18
APLSApellis Pharmaceuticals, Inc.	14,312	—	—		2026-02-27

A

AGILENT TECHNOLOGIES, INC.

$725.1K

5,548 sh

RCKT

ROCKET PHARMACEUTICALS, INC.

$281.1K

67,082 sh

APLS

Apellis Pharmaceuticals, Inc.

—

14,312 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 2

Stock	Transaction	Date	~6mo later
RCKTROCKET PHARMACEUTICALS, INC.	Grant — · 22,862 sh	2026-06-18	—
AAGILENT TECHNOLOGIES, INC.	Sell $216.7K · 1,600 sh	2026-05-29	—
APLSApellis Pharmaceuticals, Inc.	Grant — · 14,312 sh	2026-02-27	—
AAGILENT TECHNOLOGIES, INC.	Sell $389.5K · 2,600 sh	2025-12-01	—

RCKTGrant

2026-06-18 · ROCKET PHARMACEUTICALS, INC.

22,862

—

ASell

2026-05-29 · AGILENT TECHNOLOGIES, INC.

$216.7K

—

APLSGrant

2026-02-27 · Apellis Pharmaceuticals, Inc.

14,312

—

ASell

2025-12-01 · AGILENT TECHNOLOGIES, INC.

$389.5K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.